Canada markets closed

Kura Oncology, Inc. (KURA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
19.00+0.25 (+1.33%)
At close: 04:00PM EDT
19.00 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.45B
Enterprise Value 1.04B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)3.64
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -6.93

Trading Information

Stock Price History

Beta (5Y Monthly) 0.87
52-Week Change 395.07%
S&P500 52-Week Change 321.08%
52 Week High 324.17
52 Week Low 37.41
50-Day Moving Average 320.63
200-Day Moving Average 313.77

Share Statistics

Avg Vol (3 month) 31.14M
Avg Vol (10 day) 31.07M
Shares Outstanding 576.18M
Implied Shares Outstanding 676.18M
Float 849.82M
% Held by Insiders 11.08%
% Held by Institutions 1105.93%
Shares Short (Apr 15, 2024) 410.12M
Short Ratio (Apr 15, 2024) 411.66
Short % of Float (Apr 15, 2024) 413.42%
Short % of Shares Outstanding (Apr 15, 2024) 413.28%
Shares Short (prior month Mar 15, 2024) 410.3M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-22.90%
Return on Equity (ttm)-37.34%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -164.96M
Net Income Avi to Common (ttm)-152.63M
Diluted EPS (ttm)-2.08
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)423.96M
Total Cash Per Share (mrq)5.57
Total Debt (mrq)17.2M
Total Debt/Equity (mrq)4.33%
Current Ratio (mrq)12.26
Book Value Per Share (mrq)5.34

Cash Flow Statement

Operating Cash Flow (ttm)-124.82M
Levered Free Cash Flow (ttm)-63.9M